Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services.

MLA

Abou-Foul, A. K., et al. “Cervical Lymphadenopathy Following Coronavirus Disease 2019 Vaccine: Clinical Characteristics and Implications for Head and Neck Cancer Services.” Journal of Laryngology & Otology, vol. 135, no. 11, Nov. 2021, pp. 1025–30. EBSCOhost, https://doi.org/10.1017/S0022215121002462.

APA

Abou-Foul, A. K., Ross, E., Abou-Foul, M., & George, A. P. (2021). Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services. Journal of Laryngology & Otology, 135(11), 1025–1030. https://doi.org/10.1017/S0022215121002462

Chicago

Abou-Foul, A K, E Ross, M Abou-Foul, and A P George. 2021. “Cervical Lymphadenopathy Following Coronavirus Disease 2019 Vaccine: Clinical Characteristics and Implications for Head and Neck Cancer Services.” Journal of Laryngology & Otology 135 (11): 1025–30. doi:10.1017/S0022215121002462.